Scholarlink

Objectives <p>To determine metabolic and hormonal profiles in women with functional hypothalamic amenorrhea (FHA) with normal body mass index (BMI).</p> Methods <p>In FHA (<i>n</i> = 69) and controls (<i>n</i> = 69), matched for age and BMI lipid, fasting plasma glucose (FPG) and insulin (Ins) levels along with hormonal profile were determined.</p> Results <p>FHA showed slightly lower FPG (− 8.2%, <i>p</i> = 0.001) contrary to the controls with no differences in lipid profile. In the FHA group, BMI was positively correlated with Ins (<i>r</i> = 0.57, <i>p</i> &lt; 0.001) and negatively with high-density lipoprotein cholesterol (HDL-C; <i>r</i> = − 0.58, <i>p</i> &lt; 0.001). Regarding hormonal profile, FHA showed higher prolactin (PRL; + 61.6%) and thyroid-stimulating hormone (TSH; + 4.0%) levels compared to the controls (all <i>p</i> &lt; 0.05). FHA had higher androgen levels reflected by higher total testosterone (TT; + 22.2%) and 17-hydroxyprogesterone (17-OHP; + 88.9%) levels (all <i>p</i> &lt; 0.05) in contrary to the remainder.</p> Conclusion <p>FHA women with normal BMI present unfavorably altered hormonal profile reflected by hyperandrogenemia and slightly lower, but significant, FPG level. The findings confirm the importance of assessing both metabolic and hormonal panels in FHA women despite normal BMI.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Functional hypothalamic amenorrhea (FHA) in women with normal body mass index (BMI): metabolic and hormonal profiles

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月17日

查看全文
  • Daryna Barouka,
  • Olga Kacalska-Janssen,
  • Robert Jach,
  • Magdalena Piróg

摘要

Objectives

To determine metabolic and hormonal profiles in women with functional hypothalamic amenorrhea (FHA) with normal body mass index (BMI).

Methods

In FHA (n = 69) and controls (n = 69), matched for age and BMI lipid, fasting plasma glucose (FPG) and insulin (Ins) levels along with hormonal profile were determined.

Results

FHA showed slightly lower FPG (− 8.2%, p = 0.001) contrary to the controls with no differences in lipid profile. In the FHA group, BMI was positively correlated with Ins (r = 0.57, p < 0.001) and negatively with high-density lipoprotein cholesterol (HDL-C; r = − 0.58, p < 0.001). Regarding hormonal profile, FHA showed higher prolactin (PRL; + 61.6%) and thyroid-stimulating hormone (TSH; + 4.0%) levels compared to the controls (all p < 0.05). FHA had higher androgen levels reflected by higher total testosterone (TT; + 22.2%) and 17-hydroxyprogesterone (17-OHP; + 88.9%) levels (all p < 0.05) in contrary to the remainder.

Conclusion

FHA women with normal BMI present unfavorably altered hormonal profile reflected by hyperandrogenemia and slightly lower, but significant, FPG level. The findings confirm the importance of assessing both metabolic and hormonal panels in FHA women despite normal BMI.